The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery

Recruiting now

Conditions studied: Thyroid Cancer

In brief

This study aims to investigate the value of 68Ga-FAPI PET/CT in detecting recurrent and metastatic lesions in patients with thyroid cancer after surgery.

Key facts

Study ID

NCT06800768

Run by

Ruijin Hospital

People needed

40

Starts

2025-02-01

Expected to finish

2030-01-31

Last updated by the study team

2025-01-30

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with thyroid cancer who have undergone surgery and are suspected of recurrence or metastasis during clinical evaluation.
• Signed and dated informed consent form.
• Commitment to comply with research procedures and co-operation in the implementation of the full research process.
• Aged 18-80 years old.

You may not qualify if…

• Patients with serious illnesses that researchers consider unsuitable for participation in this clinical study. Such as severe heart and lung failure, severe bone marrow suppression, severe liver and kidney dysfunction, etc.
• Intestinal perforation, complete intestinal obstruction.
• Pregnant women and women who may be pregnant, women who are breastfeeding.
• Non-compliant person.

Where it is running

• Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine — Shanghai, Shanghai Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.